Showing posts with label Macquarie Research. Show all posts
Showing posts with label Macquarie Research. Show all posts

29 April 2019

Yes Bank : Long road to redemption :Macquarie Capital Securities (India)

Please Share:: Bookmark and Share �� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��

26 December 2014

MacVisit:Wonderla Holidays Multiplying wonders :: Macquarie

Please Share:: Bookmark and Share

�� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��

24 December 2014

Macquarie Research, 2015 top stock Ideas,

Please Share:: Bookmark and Share

�� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��

27 August 2013

Eye on India Facts are facts, but perception is reality :: Macquarie Research

Eye on India
Facts are facts, but perception is reality
Event
 Q1FY14 results beat estimates: 100+ stocks under our coverage reported
PAT 7% better than our expectation. Sales revenue was muted as expected
at 5% growth YoY, but operating margins surprised by 60bps. IT, Telecom
and Pharma were the key sectors to see earnings upgrades.
 Key changes to top 10 ideas: We replace Bharti with Idea, as Bharti’s large
USD debt is posing risks in the face of sharp currency depreciation while
Idea’s earnings have seen the highest % upgrades this earnings season. For
the list of other stocks with positive earnings revisions see Fig 17.
Impact
 Lowest quarterly revenue growth since Q1FY11 due to weak macro…:
The 5% revenue growth reflects the tough macro environment that companies
are operating in. Waning top-line growth is reflective of the sharp slowdown in
GDP growth to below 5% over the past couple of quarters.
 …but better than expected PAT growth: The 6% growth in PAT (ex-Oil
and gas) was 7% better than our estimates, driven by power, financials
and Tata Steel.
 PSU stocks were particularly weak: PSU stocks across financial and
energy sectors showed weak results. Excluding 6 PSU stocks in Sensex, net
profit growth was 9% yoy vs -2.7% yoy, led by a 120bps improvement in
operating margins.
 Operating margins have bottomed out…: EBITDA margins came in at
around 20.6%, which was up 20bps YoY but importantly higher than our
estimate by 60bps. This is likely as a result of moderating inflation trend and
stable oil prices during Q1FY14 that helped improve margins.
 …but may be at risk due to weakening currency: With INR touching all
time lows and crude prices inching up to US$110/bbl, the risk of input cost
pressures coming back has increased. Consensus is currently building in 11%
earnings growth for Nifty, driven by 5% revenue growth and 100bps
expansion in margins. While revenue assumptions are muted, margin
assumptions may be at risk given weak currency. However, as government
spending returns pre election, revenue growth has potential to surprise
upwards.
 Earnings revision ratio worsened; FY14 est downgraded further: The
ratio lost momentum in the last 3-4 months, as downgrades picked up with
falling demand. Earnings revisions are negative for most sectors barring IT,
Telecom and Media.
Outlook
 Market – what is left to say! It was mayhem that we saw, but the bright spot
was the bottoming out of the steel sector. Clearly domestic economy-related
sectors are coming under pressure and even the loved defensives are being
questioned. We would recommend following earnings upgrades as a prudent
stock selection criterion and be wary of stocks over owned by FIIs.

23 July 2013

Where are the customers’ yachts?: Macquarie Research

Event
 Q1FY14 earnings preview reflect low demand: For 128 stocks under our
coverage, we are forecasting a meagre 5% YoY revenue growth for Q1, which
is the lowest level seen over a decade and almost in line with GFC. This is
driving a 5% increase in EBITDA, though PAT is expected to show no growth
given MTM forex losses. We think Metals and Cement will be the worst
performers, while Private Banks, NBFCs and Power sector will show the
fastest growth.
 Earnings revisions are a key driver of stocks prices; however, several have
run up against this trend and look expensive – these include ACEM, UTCEM,
INFY and ZEETV. On the other hand, stocks where positive earnings
revisions are holding up and yet have underperformed include REC, PFC,
ICICI, YES and NTPC.
Impact
 Revenue growth at all-time low: Impact of a stalling economy is well visible
now, with revenue growth in the vicinity of GFC levels of around 5%. We do
expect that there will be revival in rural demand as the monsoon is
progressing well. Also, government spending is expected to increase by 30%
YoY in the 2
nd half as it prepares for general election due early next year.
 Margins have stabilised: EBITDA margins have benefited from the
moderation in inflation. There is a bit of worry that the fall in INR might stoke
inflation again. However, commodity prices are already falling globally as the
slowdown in China has pushed most commodities in an oversupply situation.
There is risk from crude oil, though, given the unrest in Egypt, but the
government is absorbing this with measured increase in diesel prices.
 Power sector is making a comeback: Sectors expected to show profit
growth of 10% or more include power, telecom, pharma, consumer and
media. Amongst financials, PSU banks are expected to drag growth down
with an 8% decline in profits, while private banks and NBFCs are expected to
show 23% and 21% profit growth, respectively. On the negative side, cement
and metals would likely be the worst-performing sectors with negative
revenue growth leading to decline in profits. Other sectors expected to show
decline in profits include autos and real estate.
 Consensus expectations are conservative: Consensus is building in 12–
13% earnings growth driven by 8% revenue growth and a slight improvement
in EBITDA margins. We think that as GDP growth recovers closer to 6% from
5%, corporate revenue growth has potential to surprise upwards.
Outlook
 Holding up despite FII outflows: Markets have held up well despite FII flows
turning negative. Once the anxiety over phasing out of QE3 has eased, focus
will shift back to domestic economics and we are hopeful of a recovery in 2nd
half, driven by improved government spending and prospects of normal
monsoon. Consider cyclical stocks.

22 July 2013

Wockhardt Waluj UK import alert – no sales hit: Macquarie Research,

Event
 WPL said that it has received an import alert from the UK MHRA for its
manufacturing plant at Waluj. This means all products from this facility (both
the oral and injectable block) will be blocked from entry into the UK market
until the manufacturing issues are resolved.This is the same facility that was
hit by a US import alert in May-2013.
 Sales to the UK market from the Waluj plant in FY13 were around ~UK£6-
8m. Given the products are already available to be shipped from alternative
sites (which are UK MHRA compliant), WPL expects this UK MHRA import
alert on Waluj to have a negligible impact on its financials.
 We maintain our OP rating but cut our TP to Rs1,440 (from Rs1,680) as we
expect news-flow to weigh on valuation multiples in the near-term until the
regulatory issues at Waluj are resolved. We see near-term volatility existing
on the stock due to this import alert.
Impact
 Early resolution of US import alert critical: Before this UK MHRA import
alert, in May-13 the US FDA had put an import alert on the same Waluj
facility. WPL was guiding to the potential loss of US$100m in annual sales
(v/s our estimate of US$135m) due to the US import alert at the facility. Half of
the pending 46 ANDAs with the US FDA are from the Waluj facility (of which
12 were filed recently & hence near-term approval was not anticipated).
 Remedial measures being pursued by WPL (site transfer of high-value
products or segregating compliant Oral block into a separate facility), if
successful, could provide upside risk. We think the speed with which WPL can
resolve these regulatory issues is going to be critical (unlikely in FY14).
Earnings and target price revision
 No change to our earnings estimate as WPL has approvals to ship products
from alternative sites. However, we expect the news-flow to weigh on
valuation multiples near-term given the regulatory uncertainty and hence cut
our TP to Rs1,440 @12x FY14E P/E (v/s Rs1,680 @14x FY14E P/E).
Price catalyst
 12-month price target: Rs1,440.00 based on a PER methodology.
 Catalyst: Resolution of regulatory issues, niche launches
Action and recommendation
 We do acknowledge that the regulatory action is a negative surprise causing
near-term pressure. However, valuations are attractive, with WPL trading at
~7.5x FY14E PER, despite industry high return ratios (ROE and ROIC of
>40%), a strengthened balance sheet (D/E<.5x) and strong FCF generation
>US$150m in FY14. Maintain Outperform.

23 August 2012

Tata Steel- Leverage cuts both ways ::Macquarie Research,


Tata Steel
Leverage cuts both ways
Event
 Lower sales volume hits earnings: As was well expected given the
slowdown in sales volume, Tata Steel Q1 earnings missed expectations. We
have cut our earnings estimates for FY13 and FY14 by 23% and 13%,
respectively, to build in lower sales volume for both Europe and India. We cut
our target price to Rs306 based on 7x PER (earlier Rs404) and downgrade
to Underperform from Neutral.

15 June 2012

Macquarie Research:: HDFC- The last bastion falls Structural de-rating in the making; Downgrade to UP



HDFC
The last bastion falls
Structural de-rating in the making; Downgrade to UP
We downgrade HDFC Ltd to an anti-consensus Underperform rating from
Outperform with a TP of Rs550, which offers 17% downside. We believe a
structural de-rating is likely because the quality of earnings and ROE reported is
being driven more by its corporate book and aggressive accounting practices.
Mortgage profitability is declining structurally and regulations have become
adverse. All this would make it tougher for HDFC Ltd to sustain its super-normal
multiples/valuations. Though near-term catalysts are absent, the de-rating call is
more a longer-term view as the stock appears fundamentally overvalued.
ROE driven by corporate book; getting riskier structurally
Over the past eight years, HDFC has increased the share of the corporate book
(loans to real estate developers, lease rentals etc) in the overall loan portfolio
from 29% to 37%. The issue is that housing loan profitability has been falling
structurally and the company has been resorting to higher-risk non-retail
categories to drive up ROE. We estimate the non-retail book now generates
more than 30% of ROE and contributes more than 65% to HDFC’s profits.
Retail housing loan profitability falling structurally
Over the past several years, competition in retail housing has picked up, and
some of HDFC’s peers have grown at exceptional rates. The premium product
pricing that HDFC Ltd used to enjoy no longer exists. Competition is intense and
likely to increase since banks have limited opportunities in the corporate
segment this year. Retail business ROE has also been affected by regulatory
changes and we estimate the retail business now generates a poor ROE of
around 13-14% compared with 20%-plus five years ago.
Accounting practices used to inflate earnings and ROE
Over the past two years, HDFC Ltd has been adopting aggressive accounting
practices by passing provisioning through reserves and also making the
adjustments for zero-coupon bonds (ZCBs) through reserves. We believe FY11
and FY12 earnings are overstated by 38% and 24% respectively and reported
ROE would have been 600 and 400 bps lower at 16% and 18% respectively if
the adjustments had been made through the P&L. In other words, earnings
growth has been managed, in our view.
Regulations – another overhang
We also think investors are underestimating the longer-term implications of
regulatory changes and consequently this also presents a strong case for derating
in our view. The regulator has increased the provisioning requirements,
has banned pre-payment charges, and asked for re-alignment of rates for old
and new customers, all of which could have an impact, especially in a predatory
pricing environment. We also expect capital requirements to be increased,
similar to the banking and NBFC sector, and this is one big event risk (with a
high probability of happening) that the market is not factoring in, in our view.
TP cut by 30%, driven by sharp cut in multiples
We cut our TP by 30% to Rs550 on account of a sharp reduction in our target
multiple. We are now valuing the core business at 2.0x P/BV compared to 4.0x
previously. The reduction in multiple is on account of: i) lower retail business
ROE driven by lower spreads in the retail business and higher capital
requirements; and ii) a sharp reduction in corporate business ROE driven by
factoring in credit losses and higher capital requirements.


16 April 2012

Infosys Technologies - Black Friday :Macquarie Research,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Infosys Technologies
Black Friday
Event
 We downgrade Infosys to Neutral. Infosys disappointed the market by
missing its muted 4Q guidance and providing FY13 outlook that would lead to
earnings downgrade across the street. While the stock declined 12% on
Friday, we do not see value emerging given the bleak growth prospects.
Better earnings performance from other IT vendors during the next two weeks
can further weaken the investment argument for Infosys.
Impact
 Is Infosys FY13 guidance conservative? We do not think that Infosys mgmt
is building in extra caution while guiding for 8-10% US$ revenue growth next
year. Given the delay in new project launches seen by Infosys in March, we
think a significant beat on 1Q guidance is difficult. This implies the CQGR ask
rate for the remaining three quarters to meet the 10% growth target would be
5%. With a fluid macro environment and the company facing a slowdown in its
largest vertical, chances of beating the 5% CQGR are slim, in our view.
 Global tech results and Infy guidance – the disconnect. The CEO
mentioned on the call that higher share of discretionary revenues makes the
comp vs. other Indian vendors tough. While the Infy client portfolio is slightly
more skewed to discretionary services, the data point on new software license
sales from software vendors and Accenture consulting order guidance
indicate stable discretionary spend scenario.
 Estimate changes. We now forecast 9% US$ revenue growth for FY13 (vs.
12.5% earlier). Infosys has guided for 50-100bps margin decline, largely on
account of lower utilisation in FY13. The decision to keep wages flat provides
a margin cushion to the company. This, coupled with weak INR (forex
estimates unchanged) should restrict margin erosion to 20bps, in our view.
 Sector implications: Sequential decline at the BFSI vertical and North
American geo were the key 4Q disappointments and cast worries on vendors
with exposure to this vertical/geo. Our understanding from the Infy earnings
call was that it’s possible other vendors addressing different portfolios at the
same client might have not been affected by the ramp downs. Definite proof of
this is likely in the results from other vendors over next two weeks.
Earnings and target price revision
 We have reduced our FY13/FY14 EPS by 4%. Our new DCF-based target
price of Rs2,450 (was Rs2,950) implies a target PER multiple of 15x.
Price catalyst
 12-month price target: Rs2,450.00 based on a DCF methodology.
 Catalyst: Up: Raise in FY13 guidance, Down: Superior results from peers
Action and recommendation
 We do not think the 12% sell-off is overdone and rate the stock Neutral.
Investors looking to shift weight should consider TCS and Wipro, in that order.

12 April 2012

India Cements -Cheap but for a reason ::Macquarie Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


India Cements
Cheap but for a reason
Event
 Downgrading to Neutral: Taking stock post the recent excise duty hike and
building in higher cement prices and costs, we believe that ICEM now looks
fairly valued. We have adjusted our earnings and TP marginally (by less than
5%). Our new TP is Rs112 (previous Rs109) as we roll forward. We expect
penalties by the Competition Commission of India (CCI) and cement price
decline during the monsoon season to be key negative triggers ahead.
Downgrade to Neutral.
Impact
 Valuations – building in perpetual margin expansion by 5%+: Our DCF
analysis shows that at a 9% volume growth assumption, ICEM’s current stock
price is factoring in EBITDA/t improvement of around 5%+ pa. We think this is
a very aggressive assumption given the oversupply in the market.
 Our assumptions remain optimistic: We are building in 10% YoY volume
growth for CY12 as well as flat EBITDA per ton of Rs953. This is based on the
assumption that the current pricing discipline in the industry will continue.
 Consensus is not building in cost savings: Consensus forecasts are 2%
and 12% below our estimates for FY13 and FY14, respectively. Consensus
has yet to recognize the 9% reduction in taxes for import of coal. Also,
consensus is probably not building in any benefit of the upcoming ramp-up of
captive power plants and development of its coal mine in Indonesia.
 Penalty by Competition Commission could take away 80% of net profit:
We believe that CCI is in the last stages of completing its enquiry against the
cement companies and will probably announce penalties in the next month or
so. Based on recent trends, we think it is likely to be 6-7% of total revenue, or
around 80% of net profit.
Earnings and target price revision
 We have increased earnings for FY13 by 5% and fine-tuned FY14.
Price catalyst
 12-month price target: Rs112.00 based on a DCF methodology.
 Catalyst: Penalty by CCI possibly in April and cement price declines by June.
Action and recommendation
 Downgrading to Neutral: While India Cement doesn’t look expensive vs
historical EV/EBITDA, this is no bull market either. Given the risk factors
related to the cartel’s continued existence, prolonged periods of oversupply,
and impending penalties, we advise booking some profit after the 50-60%
rally from the Jan1, 2012 bottom. We believe that the stock has reached its
fair value and would be more comfortable when fundamentals recover.

Ultratech Cements - Missed opportunity ::Macquarie Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��



Ultratech Cements
Missed opportunity
Event
 Sell – negative triggers ahead: Taking stock post the recent excise duty
hike, building in higher cement prices and costs, we believe that UTCEM
looks quite expensive. We cut our earnings estimates by 1-8% over the next
three years and adjust TP to Rs883 (Rs849 earlier) as we roll forward. We
expect penalties by the Competition Commission of India (CCI) and cement
price declines during the monsoon season to be key negative triggers ahead.
Maintain Underperform.
Impact
 Valuations – building in perpetual margin expansion by 9%: Our DCF
analysis shows that at 7% volume growth assumption, UTCEM’s current stock
price is factoring in EBITDA/t improvement by around 9% pa. We think this is
a very aggressive assumption given the oversupply in the market.
 Our assumptions remain optimistic: We are building in an 11% YoY
volume growth for CY12 and also building in flat EBITDA per ton of Rs973.
This is based on the assumption that the current pricing discipline in the
industry will continue.
 So is consensus: Consensus forecasts are in line with our estimates for
FY13. However, we are ahead of consensus by 17% for FY12E. We believe
consensus has yet to build in the price hikes achieved in January-March
2012. We are also around 13% higher for FY14E, although we are not sure
why consensus has such a different view here, as compared to ACC and
ACEM.
 Penalty by Competition Commission can take away 50% of net profit:
We believe that CCI is in its last stages of completing the enquiry against the
cement companies and will most likely announce penalties in the next month
or so. Based on recent trends, it is likely to be 6-7% of total revenue or around
50% of net profit.
Earnings and target price revision
 We reduce our estimates by 1%/5%/8% for FY12/13/14, respectively.
Price catalyst
 12-month price target: Rs883.00 based on a DCF methodology.
 Catalyst: Penalty by CCI possibly in April and cement price declines by June.
Action and recommendation
 Maintain Underperform: UTCEM is currently trading at a 17x FY13E PER
which is at the higher end of the historical range, and seems expensive as it is
based on maintaining pricing discipline. It also factors in a possibility of margin
expansion which looks unlikely. We suggest investors book profits and wait
for cement price correction to buy for possible dividend yield. We think that by
allowing price discipline, Ultratech may have missed the opportunity to drive
the consolidation in the industry and emerge as the undisputed leader.

Associated Cements Don’t associate at this price ::Macquarie Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Associated Cements
Don’t associate at this price
Event
 Sell – negative triggers ahead: Taking stock post the release of its CY11
annual report, building in higher cement prices and costs, we believe that
ACC looks quite expensive. We have cut our earning estimates by 16-27%
over the next three years but maintain our target price as we roll forward.
Expect penalties by Competition Commission of India (CCI) and cement price
decline in monsoon season to be key negative triggers ahead. Maintain
Underperform.
Impact
 Valuations – building in perpetual margin expansion by 13%: Our DCF
analysis shows that at 7% volume growth assumption, ACC current stock
price is factoring in EBITDA/t improvement by around 13% pa. We think this is
a very aggressive assumption given the oversupply in the market.
 Our assumptions remain optimistic: We are building in 10% volume growth
for CY12 and also building in higher EBITDA per ton of Rs771 or Rs63/t
higher YoY. This is based on the assumption that the current pricing discipline
in the industry should continue.
 But consensus is even higher: Consensus forecasts remain 4% and 8%
higher than our estimates for CY12 and CY13, respectively. It does appear
that consensus has built in the cement price hikes but is severely
underestimating the cost increase.
 Penalty by Competition Commission could take away 50% of net profit:
We believe that CCI is in last stages of completing the enquiry against the
cement companies and most probably will announce penalties in next month
or so. Based on recent trends, it is likely to be 6-7% of total revenue or around
50% of Net Profit.
Earnings and target price revision
 We are reducing our estimates by 16%19%/27% for CY12/13/14,
respectively.
Price catalyst
 12-month price target: Rs799.00 based on a DCF methodology.
 Catalyst: Penalty by CCI possibly in April and cement price declines by June.
Action and recommendation
 Maintain Underperform: ACC is trading at 20x CY2012E PER which is at the
higher end of the historical range, which seems expensive as it is based on
pricing discipline being maintained. Also it is factoring in the possibility of
margin expansion which we think looks unlikely. We recommend investors
book profits and wait for cement price correction to buy for possible dividend
yield.

Grasim Industries Cheap but will feel headwinds ::Macquarie Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Grasim Industries
Cheap but will feel headwinds
Event
 Downgrade to Neutral: We believe Grasim will feel the headwinds of
stagnating earnings and potential penalty by the Competition Commission of
India on its subsidiary Ultratech. However, the stock does not look expensive
to us and offers diversified earnings given the conglomerate structure. Thus,
we downgrade Grasim to Neutral from Outperform. We marginally reduce our
earnings estimates (3–5%) and cut our TP to Rs2,757 (from Rs2,851).
Impact
 Cement – our assumptions remain optimistic: We build in 11% YoY
volume growth for CY12 as well as flat EBITDA/t of Rs973. This is based on
the assumption that the current pricing discipline in the industry will continue,
despite the severely oversupplied market.
 Penalty by Competition Commission could erase 27% of net profit: We
believe that CCI is in the last stages of completing its enquiry into the cement
companies and likely to announce penalties in the next month or so. Based on
recent trends, this is likely to be 6-7% of total revenue or around 27% of net
profit.
 Bearish cotton outlook to weigh on Viscose Staple Fibre (VSF) prices:
Our global soft commodities team forecasts that fundamentals will continue to
loosen for cotton as world supply improves after last year’s bumper harvests
and as demand continues to weaken on the back of poor retail demand,
destocking and switching to synthetics. There is some short-term price
support from the US plantings and Chinese reserve buying, which may give
way to bearish fundamentals, especially on the demand side.
 Consensus numbers slightly bullish: We are 3% and 4% lower than
consensus on FY13E and FY14E, respectively, given our more muted view of
the VSF business outlook.
Earnings and target price revision
 We reduce our FY13E and FY14E earnings by 3% and 5%, respectively.
Price catalyst
 12-month price target: Rs2,757.00 based on a DCF methodology.
 Catalyst: Penalty by CCI and possible cement price drops post June.
Action and recommendation
 Downgrade to Neutral: In our view, investors who are not concerned about
CCI penalties may want to own this name as opposed to its subsidiary,
Ultratech Cements (UTCEM IN, Rs1,490.65, Underperform, TP: Rs883).

Ambuja Cements Silver Jubilee year, book some profit ::Macquarie Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Ambuja Cements
Silver Jubilee year, book some profit
Event
 Sell – negative triggers ahead: Taking stock post the release of the CY11
annual report which builds in higher cement prices and costs, we believe that
ACEM loos really expensive. We cut our earning estimates by 6-23% over the
next three years and cut our TP to Rs110 from Rs119, even as we roll
forward. We expect penalties by Competition Commission of India (CCI) and
declining cement prices during the monsoon season to be key negative
triggers ahead. Maintain Underperform.
Impact
 Valuations – building in perpetual margin expansion by 7%: Our DCF
analysis shows that at 7% volume growth assumption, ACEM’s current stock
price is factoring in EBITDA/t improvement by around 7% pa. We think this is
a very aggressive assumption, given the oversupply in the market.
 Our assumptions remain optimistic: We are building in 9% volume growth
for CY12 and also building in higher EBITDA/t of Rs993, or Rs99/t higher
YoY. This is based on the assumption that the current pricing discipline in the
industry will continue.
 But consensus is even higher: Consensus forecasts remain 5% higher than
our estimate for CY12 and CY13, respectively. It does appear that consensus
has built in the cement price hikes but is severely underestimating the cost
increase.
 Penalty by Competition Commission can take away 50% of net profit:
We believe that CCI is in its last stages of completing the enquiry against the
cement companies and will most likely announce penalties in the next month
or so. Based on recent trends, it is likely to be 6–7% of total revenue or
around 50% of Net Profit.
 No special dividend: This being the 25th year of ACEM, many anticipated a
special dividend which did not materialise. We expect Holcim (the parent
company) to take cash through dividends and not through royalties as some
have suggested.
Earnings and target price revision
 We reduce our estimates by 6%/11%/23% for CY12/13/14, respectively.
Price catalyst
 12-month price target: Rs110.00 based on a DCF methodology.
 Catalyst: Penalty by CCI possibly in April and cement price declines by June.
Action and recommendation
 Maintain Underperform: ACEM is currently trading at 18x CY12E PER, the
higher end of the historical range, which seems expensive as it is based on
maintaining the pricing discipline. It is also factoring in the possibility of margin
expansion, which we think looks unlikely. We suggest investors book profits
and wait for a cement price correction to accumulate for possible dividend
yield.

India cement sector Costs, capacity & cartel = cash out ::Macquarie Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


India cement sector
Costs, capacity & cartel = cash out
Cash out time
Cement stocks have witnessed a strong rally in the last 12 months,
outperforming the Nifty by 36%, driven by the longevity of pricing discipline. With
stocks trading at 18-19x PER and the chances of a hefty penalty from the
Competition Commission of India (CCI) looming ahead, the risk/reward appears
unfavourable. Moreover, with continued capacity additions and rising costs,
earnings growth should remain elusive for at least another two years. We remain
Underweight on the Indian cement sector.
Cement price at all-time highs – where is the money?
Our study of 16 cement companies shows that since 1996, i.e. in the last 15
years, the incremental EBITDA made by these companies cumulatively was just
US$2bn, and the bulk of this came just in the three years from 2006-08. We
believe that the cement industry is again in a phase where the fight will be to
sustain earnings, and we don’t see things changing over the next three years.
Costs, costs, and costs – and will keep rising
In the past four years, production costs have risen 50%, and this includes
subsidies, like diesel and coal from Coal India. Rising costs have helped improve
price discipline, and the industry has been able to raise cement prices by 35%,
but this is not enough for margin expansion. Unfortunately, the cost rises have
been structural and may require substantial changes like captive coal mines, etc
to reverse; we think this is at least three years away.
Capacity still outpacing demand
We are expecting 50mt of additional capacity in the next two years, while
incremental demand is likely to remain less than 35mt. This will keep cement
capacity utilisation below 80%. Also the installed capacity share of the top three
companies in the country has fallen from 45% (in FY08) to just 38% now. On the
other hand, demand growth has declined from an average of 10% pa in the past
four years to around 6-7%. With our muted view of the investment cycle and
reduced affordability of real estate, we don’t see demand growth exceeding 8%
pa over the next two years.
CCI on the verge of levying penalties for cartelisation
CCI finished hearings against 42 cement companies in late February and should
be ready with penalties by April. We expect penalties of about 7% of total
revenue (last three years’ average), equal to 5-6% of market cap for every year
of investigation. Global experience tells us that stocks correct by 20%+ on such
penalties. See our report Investigations & Oversupply (June 23, 2011).
Costly – Valuations expensive and building in a bull cycle
Cement stocks are now trading at all-time high valuations, with well above
trough-cycle earnings. To justify current valuations, we need EBITDA margins to
improve by 50%, which looks highly unlikely given oversupply. Moreover, we are
not sure if the companies will be able to retain these earnings in view of the
possible penalties. We would sell into this rally. Our key sell ideas are ACC,
Ambuja and Ultratech.

04 April 2012

Union Bank of India -Cheap can remain cheap : Macquarie Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Union Bank of India
Cheap can remain cheap
Event
 Downgrade to Underperform: We expect Union Bank’s ROE to witness
severe pressure and fall from the 18-20% seen in FY08-11 to 12-13% by
FY14E given slower growth and asset quality issues. Downgrade to
Underperform with a revised TP of Rs185.

HDFC Bank- Good things in life rarely come cheap : Macquarie Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


HDFC Bank
Good things in life rarely come cheap
Event
 Our top pick and the only Outperform in the banking space: HDFC Bank
is our top pick in the banking space. We reiterate our Outperform with a
revised TP of Rs625.
Impact
 Asset quality expected to remain exceptionally good: HDFC Bank’s
experience on loss rates in various retail product categories continues to be
even better than what it had budgeted. Current credit costs of 1% are likely to
stabilise more around 120bps over the longer term, according to
management. It continues to judiciously make floating provisions which help it
create a countercyclical buffer. The NPL coverage ratio, including floating
provisions, is at ~125%+ – by far the best in the sector. It has largely avoided
stressed sectors, exposure to infrastructure is largely in the form of working
capital loans and is lower than its peers, and in the CV segment it isn’t
exposed much to the mining belts like Karnataka, Orissa etc. Overall we don’t
expect that credit costs will spike up, but will be around 120bps.
 Liquidity and capital position – pretty comfortable: Loan growth has
broadly matched deposit growth and moreover HDFC doesn’t have a large
dependence on wholesale funding. The current Tier-1 ratio at 11.4% is very
comfortable and its internal Basel-III analysis submitted to RBI also shows
that the impact on capital ratios is minimal. It doesn’t have any hybrids in Tier-
I and other issues like investment in subsidiaries, intangibles etc. are not
there. So we don’t envisage any risk of equity dilution in the next 12-18
months.
 Growth continues to surprise us: HDFC Bank for the past several years
has grown at least 500bps faster than the system. Loan growth of 22% YoY in
3Q12 was much higher than system loan growth of 17%. Growth so far has
been predominantly driven by retail assets. It is surprising that HDFC Bank
continues to grow its retail portfolio like CVs, 2-Wheelers, personal loans and
credit cards at impressive growth rates whereas other banks continue to
struggle in these segments.
Earnings and target price revision
 We have reduced EPS by 3% and 6% for FY13E and FY14E on account of
slightly lower margins and higher opex. TP is marginally adjusted upwards by
2% owing to cost of equity changes.
Price catalyst
 12-month price target: Rs625.00 based on a Gordon growth methodology.
 Catalyst: Strong earnings growth and return ratios
Action and recommendation
 Expensive valuations to stay: HDFC Bank’s expensive valuations are
unlikely to come down owing to its strong fundamentals relative to its peers.
We reiterate as our top pick with a TP of Rs625.

State Bank of India Size doesn’t matter : Macquarie Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


State Bank of India
Size doesn’t matter
Event
 Maintain Underperform with TP of Rs1,700: We remain bearish on SBI
mainly due to asset quality issues which are unlikely to abate in the near
future. Maintain Underperform.

ICICI Bank Where is the upside? Downgrade to Neutral : Macquarie Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


ICICI Bank
Where is the upside? Downgrade to
Neutral
Event
 Downgrade to Neutral on valuations, TP unchanged: After the sharp rally
recently, valuations look stretched. Downgrade to Neutral from Outperform.
Impact
 Restructuring to pick up, negative surprises can’t be ruled out: Going
ahead, the quantum of restructured assets is expected to pick up. We don’t
expect asset quality to deteriorate to the extent seen in the previous cycle.
However there is stress in certain mid-corporate and power sector exposures
that ICICI has put on its books and are likely to be restructured over the course
of the next few years.
 Aggressive guidance on credit costs: Management guidance on FY13E
credit costs (provisions on NPLs as a percentage of advances) to be around
75bps marginally higher than FY12E is aggressive in our view. If ICICI
manages to deliver these credit cost numbers on the back of higher
restructuring, we believe the market is not going to take it well. We have
conservatively built in 110bps of credit costs into our numbers. If we build in
75bps into our model, our earnings estimates would be roughly 11% higher for
FY13E.
 Growth remains a worry: Management continues to be a bit cautious on
growth. Performance with respect to the retail segment has been very
unsatisfactory and much of the growth in the past two years has come from the
corporate segment, particularly infrastructure. The bank has been struggling to
grow its retail book compared to some of its peers who have done very well.
 Risk of equity dilution is less: The proposed Basel-III norm is unlikely to
result in equity dilution for ICICI, at least in the early years of implementation as
ICICI is sufficiently capitalised. That isn’t the case with most of its peers who
would come to the market over the course of next two years to raise capital.
Hence the risk of equity dilution is also pretty low over the next two years in our
view. By that time we believe there could be some repatriation of capital from
the Canada business further giving some cushion. Management has guided
that, according to their internal calculations, they don’t need to raise any equity
capital for the next three years.
Earnings and target price revision
 We marginally increase FY13E and FY14E EPS by 3% and 1 % due to slightly
lower credit costs. No change in TP.
Price catalyst
 12-month price target: Rs855.00 based on a Sum of Parts methodology.
 Catalyst: Increase in restructured assets quantum
Action and recommendation
 See limited upside from current levels: ICICI Bank now trades at 1.5x FY13E
P/BV which is inline with its historic averages. Neutral.